Evaluating Collagen Cross-Linking (CCL) Treatment in Norway

NCT00435799 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Keratoconus

Interventions

PROCEDURE: corneal cross-linking (CCL)
DRUG: Riboflavin/dextran eyedrops
DEVICE: UV-X system

Sponsor

Ullevaal University Hospital